Sort
39,280 grants matching “leukemia”
REGULATION OF FELV REPLICATION AND PATHOGENESIS
$297,979Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA
Abelson Leukemia Virus Transformation
$297,969Tufts University Boston · R01 · FY2002 · CA
The Synthesis of Bioactive Polycyclic Natural Products
$297,898Brian M Stoltz · California Institute Of Technology · R01 · FY2011 · GM
Mechanisms of Metabolic Gene Mutations in Cancer
$297,887Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2014 · CA
Retroviral Immunotoxins for Leukemia
$297,803Daniel A Vallera · University Of Minnesota · R01 · FY2007 · CA
Genetic Determinants of Cytomegalovirus Pathogenesis
$297,792Eastern Virginia Medical School · R01 · FY2004 · CA
Late adverse Impact of Getting Hyperbilrubinemia or photo Therapy (LIGHT) study
$297,790Thomas B Newman · University Of California, San Francisco · R01 · FY2012 · HS
REGULATION OF FELV REPLICATION AND PATHOGENESIS
$297,789Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Active Immune Therapy ot Leukemia Associated Antigens and Gene Therapy
$297,769Thomas J. Kipps · University Of California, San Diego · P01 · FY2010 · CA
Determinants of Relapse Risk After BMT for ALL
$297,760Stephan A Grupp · Children'S Hosp Of Philadelphia · R01 · FY2009 · CA
TCR Diagnostics in LGL Leukemia and Immune Cytopenias
$297,737Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
Properties and regulation of p53 in tumor cells
$297,726Carol Prives · Columbia Univ New York Morningside · R01 · FY2014 · CA
Interacting motifs of alphavirus envelope proteins.
$297,714University Of Texas Medical Br Galveston · R21 · FY2003 · AI
Development and Applications of 'Designer Chromatin'
$297,702Tom W Muir · Princeton University · R01 · FY2013 · GM
PR1-specific CB T cells for Patients with Myeloid Malignancies
$297,605Jeffrey J Molldrem · University Of Tx Md Anderson Can Ctr · P01 · FY2015 · CA
Incorporating FLT3 Inhibitors into Acute Myeloid Leukemia(AML)Treatment Regimens
$297,599Mark J Levis · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
REGULATION OF FELV REPLICATION AND PATHOGENESIS
$297,590Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
TRANSCRIPTION FACTOR MUTATIONS AND HUMAN AML
$297,552Beth Israel Deaconess Medical Center · R01 · FY2004 · CA
Genetic and Molecular Studies of Drosophila Chromatin Remodeling Factors
$297,551John Walter Tamkun · University Of California Santa Cruz · R01 · FY2009 · GM
Mechanistic Problems in Eukaryotic Gene Regulation
$297,460Olke C Uhlenbeck · Northwestern University · R01 · FY2011 · GM
Validation of microRNAs as therapeutic targets in hematological malignancies
$297,452Guido Marcucci · Ohio State University · R01 · FY2013 · CA
Role of microRNAs in the regulation of CML stem cell survival and self renewal
$297,452Danilo Perrotti · Ohio State University · R01 · FY2013 · CA
Novel Immunotherapies for Lymphoid Malignancies
$297,452John C Byrd · Ohio State University · R01 · FY2013 · CA
A Novel Autotransplant Protocol for CML
$297,422University Of Texas Md Anderson Can Ctr · R21 · FY2004 · CA
Molecular Determinants of Methotrexate in Acute Lymphoblastic Leukemia
$297,398Julio C Barredo · University Of Miami School Of Medicine · R01 · FY2008 · CA